Position in VYGR
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$2,236,150
-$1,991,094 QoQ
Shares Held
638,900
-41.7% QoQ
Ownership
1.06%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1
of 22 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VYGR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Erste Asset Management GmbH holds $553,204,959 across 68 Biotechnology names. VYGR ranks #36 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AGIO |
Agios Pharmaceuticals, Inc.
|
2,154,900 | $79,968,339 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
110,210 | $59,177,259 | |
| 3 | SRPT |
Sarepta Therapeutics, Inc.
|
2,568,945 | $46,163,941 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
76,558 | $38,028,654 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
834,000 | $29,515,260 | |
| 6 | DNA |
Ginkgo Bioworks Holdings, Inc.
|
2,536,939 | $25,141,065 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,716 | $24,140,974 | |
| 8 | MIRM |
Mirum Pharmaceuticals, Inc.
|
205,000 | $23,999,350 |
All Filings in VYGR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,236,150 | 638,900 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $4,227,244 | 1,095,141 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $4,696,904 | 1,195,141 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $5,215,423 | 1,116,793 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,473,226 | 1,116,793 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,774,760 | 1,116,793 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $6,001,003 | 1,058,378 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $6,191,511 | 1,058,378 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $8,371,769 | 1,058,378 | Shares | Sole | 2024-11-26 | |
| 2024-03-31 | $9,853,499 | 1,058,378 | Shares | Sole | 2024-11-26 | |
| 2023-12-31 | $8,932,710 | 1,058,378 | Shares | Sole | 2024-11-26 | |
| 2023-09-30 | $8,202,429 | 1,058,378 | Shares | Sole | 2024-11-26 | |
| 2023-06-30 | $12,118,428 | 1,058,378 | Shares | Sole | 2024-11-26 | |
| 2023-03-31 | $8,391,394 | 1,088,378 | Shares | Sole | 2024-11-26 | |
| 2022-12-31 | $6,944,105 | 1,138,378 | Shares | Sole | 2024-11-26 | |
| 2022-09-30 | $6,739,197 | 1,138,378 | Shares | Sole | 2024-11-26 | |
| 2022-06-30 | $6,727,813 | 1,138,378 | Shares | Sole | 2024-11-26 | |
| 2022-03-31 | $9,318,498 | 1,222,900 | Shares | Sole | 2024-11-25 | |
| 2021-12-31 | $3,422,459 | 1,262,900 | Shares | Sole | 2024-11-25 | |
| 2021-09-30 | $2,532,427 | 962,900 | Shares | Sole | 2024-11-25 | |
| 2021-06-30 | $3,068,177 | 742,900 | Shares | Sole | 2024-11-25 | |
| 2021-03-31 | $2,792,559 | 592,900 | Shares | Sole | 2024-11-25 | |
| 2020-12-31 | $2,773,485 | 387,900 | Shares | Sole | 2024-11-25 | |
| 2020-09-30 | $3,658,743 | 342,900 | Shares | Sole | 2024-11-25 | |
| 2020-06-30 | $4,327,398 | 342,900 | Shares | Sole | 2024-11-22 | |
| 2020-03-31 | $3,055,185 | 333,900 | Shares | Sole | 2024-11-22 | |
| No filing history on record for this holder in this stock. | ||||||